JAK2 V617F mutation in primary myelodysplastic syndromes: a multicenter retrospective study

Autor: Dahabreh, I. Manola, K. Galanopoulos, A. Giannouli, S. and Stavropoulou, C. Vlachadami, I. Stefanoudaki, K. Palliou, E. and Katsigiannis, A. Anagnostopoulos, N. Loukopoulos, D. and Sambani, C. Voulgarelis, M. Zoi, K.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::2788c38257df0aa797b27c781cce632a
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3142282

Oral hyperfractionated cyclophosphamide and intermittent thalidomide-dexamethasone for previously treated patients with multiple myeloma

Autor: Dimopoulos, M Panayiotidis, P Grigoraki, V Poziopoulos, C Xilouri, I Kiamouris, C Tassidou, A Gika, D Stefanoudaki, K Anagnostopoulos, N others

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::70124704e1278ff5dacc4ff3bdec7b6a
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:2953950

Switch in X-inactivation in a JAK2 V617F-negative case of polycythemia vera with two acquired X-autosome translocations.

Autor: Manola KN; Laboratory of Cytogenetics, National Center for Scientific Research (NCSR) 'Demokritos', 15310 Aghia Paraskevi, Athens, Greece., Stavropoulou C, Georgakakos VN, Zoi K, Fisfis M, Evmorfiadis I, Zoi C, Pantelias GE, Stefanoudaki K, Sambani C

Publikováno v: Leukemia research [Leuk Res] 2007 Jul; Vol. 31 (7), pp. 1009-14. Date of Electronic Publication: 2007 Jan 03.

LYMPHOCYTE MARKERS AND CLINICAL EXPRESSION OF LYMPHOPROLIFERATIVE DISORDERS WITH MODERATE LYMPHOCYTOSIS

Autor: ECONOMIDOU, J CHOREMI, H KONSTANTINIDOU, N KOFINA, A and PSARRA, K STEFANOUDAKI, K PAPAYANNIS, A ECONOMOPOULOS, F and DERVENOULAS, J VLACHOS, J ANAGNOSTOU, D

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::ee95e979aae85e9774281158c21bc8ca
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3042143

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.